895 results on '"Batista, Alzir A."'
Search Results
152. Meso-tetra-(4-pyridyl)porphyrin/Palladium(II) Complexes as Anticancer Agents
153. Trichloro-bridged diruthenium (III,III) complexes: X-ray isomorphous structures of [Ph3X=O···H···O=XPh3][Ru2Cl7(XPh3)2]·0.5(CH2Cl2)(H2O)(X = As or P)
154. Dichloro(diphosphine)(2-pyridylketone)ruthenium(II) complexes
155. New routes to carbonyl complexes of general formula [RuCl2(CO)(S)(PPh3)2] (S = DMA, DMF, DMSO): crystal structure of [RuCl2(CO)(DMA)(PPh3)2] · 1/2CH2Cl2
156. The versatility of the 1,4-dithiane ligand towards the coordination chemistry of ruthenium-phosphine complexes
157. Metal complexes of 2-benzoylpyridine semicarbazone: Spectral, electrochemical and structural studies
158. Influence of ligands on the [formula omitted] isomerization in [RuCl 3(NO)(P–P)] complexes, [P–P = R 2P(CH 2) nPR 2 ( n = 1–3) and R 2P(CH 2)POR 2, PR 2–CH [dbnd]CH–PR 2, R = Ph and (C 6H 11) 2P-(CH 2) 2-P(C 6H 11) 2]
159. Mono- and dinuclear copper(I) complexes with methyl-substituted pyrimidinethiones
160. Synthesis, characterization and structure of ruthenium(II) phosphine complexes with N-heterocyclic thiolate ligands
161. A novel coordination mode for a pyridylphosphine ligand. X-ray structures of [Ru[Cl.sub.2](NO)L] (I) and [Ru[Cl.sub.2](NO)L]*DMSO (II) (L = [[[(2-py).sub.2]P[C.sub.2] [H.sub.4]POO[(2-py).sub.2].sup.-])
162. Ruthenium(II) Phosphine/Mercapto Complexes: Their in Vitro Cytotoxicity Evaluation and Actions as Inhibitors of Topoisomerase and Proteasome Acting as Possible Triggers of Cell Death Induction
163. A straightforward catalytic approach to obtain deuterated chloroform at room temperature
164. Synthesis, spectroscopic characterization and computational study of Ru(II)/DMSO complexes with monocoordinated carbazate ligands
165. Selective Coordination Mode of Acylthiourea Ligands in Half-Sandwich Ru(II) Complexes and Their Cytotoxic Evaluation
166. Heterobimetallic Ru(ii)/Fe(ii) complexes as potent anticancer agents against breast cancer cells, inducing apoptosis through multiple targets
167. Ruthenium (II) complexes with N, O-chelating proline and threonine ligands cause selective cytotoxicity by the induction of genomic instability, cell cycle arrest and apoptosis in breast and prostate tumor cells
168. Nucleobase Derivatives as Building Blocks to Form Ru(II)-Based Complexes with High Cytotoxicity
169. Biphosphinic ruthenium complexes as the promising antimicrobial agents
170. Three-dimensional cell culture models for metallodrug testing: induction of apoptosis and phenotypic reversion of breast cancer cells by thetrans-[Ru(PPh3)2(N,N-dimethyl-N-thiophenylthioureato-k2O,S)(bipy)]PF6complex
171. “Half-Sandwich”/RuII Anticancer Complexes Containing Triphenylphosphine and p-Substituted Benzoic Acids
172. A giant hybrid organic–inorganic octahedron from a narrow rim carboxylate calixarene
173. Ru(ii)/diclofenac-based complexes: DNA, BSA interaction and their anticancer evaluation against lung and breast tumor cells
174. Ruthenium(II)-mercapto Complexes with Anticancer Activity Interact with Topoisomerase IB
175. New Heteroleptic RuII/Diphosphine Complexes with Cytotoxicity against Human Breast and Murine Ascitic Sarcoma 180 Tumor Cells
176. Ru(ii)-Naphthoquinone complexes with high selectivity for triple-negative breast cancer
177. Ru(II)-Based Amino Acid Complexes Show Promise for Leukemia Treatment: Cytotoxicity and Some Light on their Mechanism of Action
178. A Supramolecular Interaction of a Ruthenium Complex With Calf-Thymus DNA: A Ligand Binding Approach by NMR Spectroscopy
179. Corrigendum: A Nanostructured Lipid System to Improve the Oral Bioavailability of Ruthenium(II) Complexes for the Treatment of Infections Caused by Mycobacterium tuberculosis
180. Cis-TransIsomerism in Metal Complexes
181. Palladium(II) complexes of 2-benzoylpyridine-derived thiosemicarbazones: spectral characterization, structural studies and cytotoxic activity
182. Experimental and Theoretical DFT Study of Cu(I)/N,N-Disubstituted-N'-acylthioureato Anticancer Complexes: Actin Cytoskeleton and Induction of Death by Apoptosis in Triple-Negative Breast Tumor Cells.
183. A Mixed Ligand Platinum(II) Complex: Spectral Analysis, Crystal Structure, Steric Demand of the Ligand, and Bioactivity of cis-[Pt(PPh3)2(L1-O,S)]PF6 (L1-O,S = N,N-Morpholine-N′-benzoylthiourea)
184. A mixed ligand platinum(II) complex: spectral analysis, crystal structure, steric demand of the ligand, and bioactivity of cis-[Pt(PPh3)2(L1-O,S)]PF6 (L1-O,S = N,N-Morpholine-N′-benzoylthiourea)
185. cis-bis(N-benzoyl-N0 ,N0 -dibenzylthioureido) platinum(II) : synthesis, molecular structure and its interaction with human and bovine serum albumin
186. cis-bis(N-benzoyl-N0,N0-dibenzylthioureido) platinum(II): synthesis, molecular structure and its interaction with human and bovine serum albumin
187. Facile Synthesis and Characterization of Symmetric N-[(Phenylcarbonyl) carbamothioyl]benzamide Thiourea: Experimental and Theoretical Investigations
188. Biomimetic oxovanadium(IV) and (V) complexes with a tridentate (N,N,O)-donor hydrazonic ligand. Two X-ray crystal structure modifications of (2-acetylpyridine-benzoylhydrazonato)dioxovanadium(V)
189. 31P{1H}-n.m.r. as a tool for identification of ruthenium isomers containing PPh3 or 1,4-bis(diphenylphosphino)butane ligands. X-ray structures of the cis-{RuCl2(PPh3)2 [4,4′-(-X)2-2,2′-bipy]} complexes [X = -H, -Me, -SMe and (-Cl, -Me)]
190. A correlation study between the conformation of the 1,4-dithiane SAM on gold and its performance to assess the heterogeneous electron-transfer reactions
191. Dichloro(diphosphine)(2-pyridyl-ketone)ruthenium(II) complexes
192. A novel coordination mode for a pyridylphosphine ligand. X-ray structures of [RuCl2(NO)L] (I) and [RuCl2(NO)L]·DMSO (II) (L = [(2-py)2PC2H4POO(2-py)2]−)
193. Characterization of a 1,4-dithiane gold self-assembled monolayer: an electrochemical sensor for the cyt-c redox process
194. On the kinetics of epoxidation of olefins by cis and trans-[RuCl 2(dppb)(2,2′-bipy)] complexes
195. A new Ru(II) complex : DNA/HSA-binding, anti-migration and biological properties in a human breast tumor cell line
196. Ruthenium Complexes Containing Heterocyclic Thioamidates Trigger Caspase-Mediated Apoptosis Through MAPK Signaling in Human Hepatocellular Carcinoma Cells
197. Ruthenium Complexes With Piplartine Cause Apoptosis Through MAPK Signaling by a p53-Dependent Pathway in Human Colon Carcinoma Cells and Inhibit Tumor Development in a Xenograft Model
198. A Mixed Ligand Platinum(II) Complex: Spectral Analysis, Crystal Structure, Steric Demand of the Ligand, and Bioactivity of cis ‐[Pt(PPh 3 ) 2 (L 1 ‐ O,S )]PF 6 (L 1 ‐ O,S = N , N ‐Morpholine‐ N′ ‐benzoylthiourea)
199. A Ru(II)-p-cymene compound bearing naproxen-pyridineamide. Synthesis, spectroscopic studies, computational analysis and in vitro anticancer activity against lung cells compared to Ru(II)-p-cymene-naproxen and the corresponding drug ligands
200. Novel lawsone-containing ruthenium(II) complexes: Synthesis, characterization and anticancer activity on 2D and 3D spheroid models of prostate cancer cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.